1Bauters C, Isner JM. The biology of restenosis [ J ]. Prog Cardiovasc Dis,1997,40(2) :107-116. 被引量：1
2Dehmer GJ,Smith KJ. Drug eluting coronary artery stents[ J]. Am Fam Physician ,2009,80( 11 ) : 1245-1251. 被引量：1
3Kang S J, Mintz GS, Park DW, et al. Mechanisms of In-Stent Restenosis After Drug-Eluting Stcnt Implantation Intravascular Ultrasound Analysis[ J]. Circ Cardiovasc lnterv,2011,4( 1 ) :9-14. 被引量：1
4George D. Dangas, Bimmer E. Claessen, Adriano Caixeta,et al. In-Stent Restenosis in the Drug-Eluting Stent Era[ J]. J Am Coil Cardio1,2010,56 ( 23 ) : 1897-1907. 被引量：1
5Wykrzykowska JJ,Arbab-Zadeh A, Godoy G,et al. Assessment of In-Stent Restenosis Using 64-MDCT: Analysis of the CORE-64 Muhicenter International Trial [ J ]. AJR Am J Roentgenol,2010, 194(1 ) :85-92. 被引量：1
6Stolker JM, Kennedy KF, Lindsey JB, et al. Predicting Restenosis of Drug-Eluting Stents Placed in Real-World Clinical Practice Derivation and Validation of a Risk Model From the EVENT Registry [J]. Circ Cardiovasc Interv,2010,3(4):327-334. 被引量：1
7Alexopoulos D,Xanthopoulou I. Coronary Stcnt Fracture:How Frequent It Is? Does It Matter[ J] ? Hellenic J Cardiol,2011,52( 1 ) : 1-5. 被引量：1
8Guildford AL,Stewart H J, Morris C,et al. Substrate-induced phenotypic switches of human smooth muscte cells :an in vitro study of in-stent restenosis activation pathways [ J ]. J R Soc Interface, 2011,8(58) :641-649. 被引量：1
9Bonta PI, Pols TW,van Tiel CM,et al. Nuclear receptor Nurrl is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle ceil proliferation and inflammation [ J ]. Circulation,2010, 121 (18) :2023-2032. 被引量：1
7Eric L Eisenstein, DBA,Kevin J. Anstrom, PhD,David F. Kong, MD,Linda K. Shaw, MS,Robert H. Tuttle, MSPH,Daniel B. Mark, MD, MPH,Judith M. Kramer, MD, MS,Robert A. Harrington, MD,David B. Matchar, MD,David E. Kandzari, MD 1,Eric D. Peterson, MD, MPH,Kevin A. Schulman, MD,Robert M. Califf, MD,李呈亿（译）,David E. Kandzari, MD.氯吡格雷的使用与药物洗脱支架植入后远期临床结果[J].美国医学会杂志（中文版）,2007,26(3):131-139. 被引量：59
8Sondergaard HM, Botker HZ, Bottcher M, et al. Percutaneous coronary intervention in patients with diabetes mellitus[J]. Ugeskr Laeger,2003,165(2) :111 - 115. 被引量：1
9Mckenna K T,Maas F,Mc Eniery PT,et al. Coronary risk tactor status after percutaneous translumininal coronary angioplasty[J]. Heart Lung,1995,24(3) :207 - 212. 被引量：1
